Further considerations include: Dehydration risk : Combined effects of diarrhoea (from both Crohn's and medication) may increase dehydration risk Medication absorption : While generally minimal, delayed gastric emptying could affect absorption of oral medications with a narrow therapeutic index Monitoring requirements : Regular assessment of disease activity markers, nutritional status, and weight trends is essential Patients should be counselled about these risks and encouraged to report any worsening gastrointestinal symptoms promptly to the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk), as distinguishing between expected side effects and disease progression requires clinical expertise
Life Sci 267:118954 Furino VDO, Alves JM, Marine DA, Sene-Fiorese M, Rodrigues CNDS, Arrais-Lima C, Mattiello SM, Castro CAD, Borra RC, Rocha MC, Malavazi I, Duarte ACGDO (2021) Dietary intervention, when not associated with exercise, upregulates irisin/FNDC5 while reducing visceral adiposity markers in obese rats
If you suspect your medication has been frozenfor example, if it was stored too close to the freezer compartment or left in a cold car overnight in winter do not use it
Everyone reacts differently based on their health and thyroid condition
Victoza (liraglutide) Victoza (liraglutide) is similar to Ozempic in that it is FDA-approved to treat the same things: improving blood sugar control in people with type 2 diabetes, and reducing cardiovascular risk in those who also have heart disease
When copper ions are too reactive, they can cause oxidation of other ingredients or irritate skin
